Find your next paid study

Alliance for Clinical Trials in OncologyNCT05334069

~$10 – $750

Bladder CancerMuscle-Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more

EV-PRIME: Phase Ib/II Study of Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy as a Bladder-Sparing Trimodality Therapy in Muscle Invasive Bladder Cancer

This phase Ib/II trial studies the side effects, best dose, and effectiveness of enfortumab vedotin (EV) in combination with pembrolizumab and radiation therap…

University of California, San FranciscoNCT06470282

~$10 – $5,625

Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more

Phase 1 Clinical Trial of a Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

This is a phase 1 clinical trial to evaluate the safety, feasibility and immunogenicity of a personalized cancer vaccine strategy in patients with solid tumors…

Washington University School of MedicineNCT06529822

Phase 2

IIT2023-13-BALLAS-VHTMT: Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

This is a Phase II, single cohort study designed to evaluate outcomes in patients with muscle invasive bladder cancer (MIBC) with variant histology who receive…

Muscle-Invasive Bladder CarcinomaTumor

~$10 – $7,500

Leslie BallasNCT06417190

Localized Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Bladder Preservation in Patients With MIBC (RAD-SG).

The purpose of this study is to examine the safety and tolerability of treatment with concurrent Sacituzumab Govitecan (SG) and adaptive radiation therapy. The…

Shilpa Gupta, MDNCT05833867

~$10 – $7,500

Phase 2

A Phase 2, Randomized, Open-label Study of Gemcitabine/Cisplatin Plus Cemiplimab (REGN2810, Anti-PD-1) With or Without Fianlimab (REGN3767, Anti-LAG-3) for Organ Preservation in Patients With Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

The goal of this clinical trial is to learn if gemcitabine/cisplatin plus cemiplimab with or without fianlimab works to treat bladder cancer in adults. The mai…

Bladder CancerMuscle-Invasive Bladder Carcinoma

Columbia UniversityNCT06571708

Observational

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

The PRIMER (Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy) trial is a pilot designed to estimate the feasibility of…

Bladder CancerNon-muscle-invasive Bladder CancerMuscle-Invasive Bladder Carcinoma

University of VirginiaNCT05790850

Observational

Randomized Controlled Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Subjects will be randomized into 2 groups (stent or no stent) prior to radical cystectomy with ileal conduit urinary diversion (RCIC). They will follow the sta…

Bladder CancerMuscle-Invasive Bladder CarcinomaUrothelial Carcinoma+3 more

Thomas Jefferson UniversityNCT07234968

Phase 2

A Modular, Open Label, Randomized Phase II/III Trial to Assess Efficacy of Combining sEphB4-HSA (EphrinB2 Inhibitor) With Immunotherapy Regimens in Patients With EphrinB2-High Solid Tumors

Patients with solid tumors that have high expression levels of EphrinB2 are treated with regimens that include EphrinB2 inhibitor, sEphB4-HSA. The primary obje…

Muscle-Invasive Bladder CarcinomaMetastatic Urothelial Carcinoma

Vasgene Therapeutics, IncNCT06493552

~$10 – $8,750

Muscle-Invasive Bladder CarcinomaRadical CystectomyIleal Conduit+1 more

Prophylactic Antibiotics in Radical Cystectomy With Urinary Diversion

Using a randomized 2 arm design, this study is being conducted to test for non-inferiority of no prophylactic antibiotic therapy versus the prophylactic oral a…